Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Insulin Aspart vs Human Soluble Insulin in Elderly T2DM
NCT00676819Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2002
- Primary completion
- Jul 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of insulin aspart in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Glucose Infusion Rate. Started Jan 2002; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00676819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00676819.